Results suggested that compound 23 was a viable lead candidate for the treatment of Hp infection, and could cause severe cellular damage, disrupt biofilms, and inhibit urease, thereby blocking ammonia cloud formation.
The β-clamp protein is identified as a therapeutic target and CID 546,407 as a promising lead for drug development, driven by robust Van der Waals forces, which avoids the massive entropic penalties hindering other compounds.
Priya Venugopal, Abel Koshy, Anuroopa G. Nadh et al.· In Silico Pharmacology· 0 citations
Invasive candidiasis, particularly caused by drug-resistant strains, has emerged as a significant contributor to morbidity and mortality among hospitalized patients worldwide, posing a serious public health challenge. With the rising resistance to conventional antifungal agents such as azoles and echinocandins, the sea...
Zhao-Ling Shi, Jia-Jia Lin, Yang Xie et al.· Mini-Reviews in Medical Chem...· 0 citations
Compound F4 emerges as a promising lead for antifungal drug development, distinguished by its broad‑spectrum activity, antibiofilm properties, and unique capacity to eliminate FLC tolerance.
Jia-Yin Wang, Qin-Li Guo, Nan Chen et al.· Drug Design, Development and...· 0 citations
Mechanistic study showed that 24a effectively inhibits biofilm formation and exerts its antibacterial effect by disrupting the bacterial cell membrane, paving the way for new strategies to combat antimicrobial resistance.
Qiong Wu, Bing-Yuan Yan, Chen Qu et al.· Chinese Journal of Natural M...· 0 citations
The development of innovative treatment medicines that can overcome drug resistance and intracellular persistence is necessary since tuberculosis (TB) continues to be a significant worldwide health burden. In this work, series of hybrid compounds containing azole moieties, imine/semicarbazide linkers, and isonicotinoyl...
Wagdy M. Eldehna, Zainab M. Elsayed, M. Korycka-Machała et al.· RSC Medicinal Chemistry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.